Moxibustion for Obesity Complicated with Climacteric Syndrome: A protocol for systematic reviews and meta-analyses

Author:

Yu Benlu1,Huang Wei1,Wang Jiajie1,Chen Xia1,Fu Chengwei1,Hu Feng1,Zhou Zhongyu1

Affiliation:

1. Hubei Provincial Hospital of TCM, Hubei University of TCM

Abstract

Abstract

Introduction Obesity complicated with climacteric syndrome (OCCS) is a disease in which estrogen levels are reduced, resulting in an imbalance between lipid metabolism, energy intake and consumption, and weight gain. Moxibustion, as non-interventional external treatment that prevents and treats diseases through thermal stimulation of relevant acupoints, has a certain advantage in the treatment of OCCS because of its affordability, convenience, efficacy, simplicity and high compliance.Consequently, we intend to carry out a comprehensive meta-analysis and systematic review on the effectiveness and safety of moxibustion for OCCS in order to contribute evidence for clinical trials. Methods and analysis From conception to December 2023, electronic searches will be conducted without language restrictions in the databases of CBM, VIP, CNKI, Wanfang, PubMed, Medline, EMBASE, and the Cochrane Library. The International Prospective Register of Systematic Reviews (PROSPERO), the Chinese Clinical Trial Registry Center, and Clinical studies will all be searched for continuing experiments.The eligible randomized controlled trials (RCTs) of moxibustion in treating OCCS should be included. The process of selecting studies, extracting data, and evaluating risk bias will be carried out separately by two reviewers. The meta-analysis of the included articles will be carried out via RevMan V.5.3 software. Meanwhile, the evidence's quality will be assessed by the Grading of Recommendations Assessment, Development and Evaluation application. Ethics and dissemination Since this is a systematic review and meta-analysis of already published studies that excludes patient information or privacy, ethics approval is not necessary. Trial registration number INPLASY202220087.

Publisher

Research Square Platform LLC

Reference35 articles.

1. Genetic studies to identify genes underlying menopausal age;Kok HS;Hum Reprod Update,2005

2. Yokota-Nakagi N, Takahashi H, Kawakami M, Takamata A, Uchida Y, Morimoto K. Estradiol Replacement Improves High-Fat Diet-Induced Obesity by Suppressing the Action of Ghrelin in Ovariectomized Rats. Volume 12. Nutrients; 2020. p. 907.

3. Menopause: evidence-based practice;Blake J;Best Pract Res Clin Obstet Gynaecol,2006

4. GBD 2015 Obesity Collaborators. Health effects of overweight and obesity in 195 countries over 25 years;Afshin A;N Engl J Med,2017

5. Overfat and Underfat: New Terms and Definitions Long Overdue;Maffetone PB;Front Public Health,2017

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3